2 High-Yielding Dividend Stocks to Buy for Passive Income in April [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
In this environment, it helps to invest in dividend stocks. The passive income they provide can help smooth out market losses in case the recent economic and geopolitical challenges lead to a market crash. Even if that doesn't happen, reinvesting dividends is a great way to boost long-term returns. With that in mind, let's consider two high-yielding dividend stocks to consider this April: Pfizer (NYSE: PFE) and Medical Properties Trust (NYSE: MPT) Image source: Getty Images. Will AI create the world's first trillionaire? Our team just released a report on a little-known company, called an "Indispensable Monopoly," providing the critical technology Nvidia and Intel both need. Continue » 1. Pfizer Pfizer boasts a juicy forward dividend yield of 6.4%. But between poor financial results and stiff competition in some areas, is it sustainable? In my view, it is. One of Pfizer's strengths is its deep portfolio of approved medicines. Even putting aside minor drugs or vaccines that m
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Pfizer protects $6.4bn heart disease blockbuster from generics, for now [Yahoo! Finance]Yahoo! Finance
- Cryptococcosis Drugs Market Outlook 2026-2036 [Yahoo! Finance]Yahoo! Finance
- Global Pharmaceutical Market Poised to Surpass USD 3.2 Trillion by 2035 – SNS Insider [Yahoo! Finance]Yahoo! Finance
- Pfizer (PFE) had its "neutral" rating reaffirmed by Citigroup Inc..MarketBeat
- Pfizer’s ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple MyelomaBusiness Wire
PFE
Earnings
- 2/3/26 - Beat
PFE
Sec Filings
- 4/27/26 - Form 4
- 4/27/26 - Form 4
- 4/27/26 - Form 4
- PFE's page on the SEC website